Page last updated: 2024-09-03

3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Becker Muscular Dystrophy

3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Becker Muscular Dystrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Khalidi, R; Ambati, J; Ambati, K; Arkle, S; Bruno, C; Chira, N; Cox, P; Gazzerro, E; Górecki, DC; McGeehan, RE; Panicucci, C; Róg, J; Young, CNJ; Zabłocki, K1

Other Studies

1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Becker Muscular Dystrophy

ArticleYear
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Acta neuropathologica communications, 2018, 04-11, Volume: 6, Issue:1

    Topics: Adenosine Triphosphate; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites; Calcium; Cells, Cultured; Collagen Type IV; Creatine Kinase; Disease Models, Animal; Male; Mice; Mice, Inbred mdx; Mice, Transgenic; Models, Molecular; Muscle Strength; Muscles; Muscular Dystrophy, Duchenne; Myoblasts; Receptors, Purinergic P2X7; Zidovudine

2018